The strong quarterly profits Integra LifeSciences reported can be attributed to strong sales in the orthopedics and neurosciences segments.
Adjusted EBITDA was $35.5 million, up two percent from the second quarter last year.
Integra also reported a GAAP net income of $15.2 million and an adjusted net income of $20.9 million for the second quarter of 2010. The company generated $19.4 million in cash flow from operations and used $5.7 million of cash on capital expenditures.
Read the news release on the second quarter for Integra LifeSciences.
Read more coverage on Integra LifeSciences:
– Integra LifeSciences Announces Milestone for Vu a-POD Device
– Integra LifeSciences Launches Dura Repair Product
– Integra LifeSciences Reports $11M Increase in Q1 Revenues
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
